MicroRNA-155 Promotes Atherosclerosis Inflammation via Targeting SOCS1
Aims: Accumulating evidence suggests that atherosclerotic progression depends on persistent and chronic inflammation in the arterial walls. MicroRNA-155 is reportedly involved in cardiovascular disease and has been implicated as a pro-inflammation regulator. Although some researchers have focused on...
Main Authors: | Yang Yang, Lixia Yang, Xing Liang, Guofu Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2015-07-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/430303 |
Similar Items
-
microRNA-155 Is Decreased During Atherosclerosis Regression and Is Increased in Urinary Extracellular Vesicles During Atherosclerosis Progression
by: Stephen Fitzsimons, et al.
Published: (2020-12-01) -
Early Secreted Antigen ESAT-6 of Mycobacterium Tuberculosis Promotes Apoptosis of Macrophages via Targeting the MicroRNA155-SOCS1 Interaction
by: Shaojun Yang, et al.
Published: (2015-02-01) -
MicroRNA-155 targets SOCS1 to inhibit osteoclast differentiation during orthodontic tooth movement
by: Yao Jiao, et al.
Published: (2023-12-01) -
MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases
by: Sergiu Pasca, et al.
Published: (2020-04-01) -
MicroRNA-155—at the Critical Interface of Innate and Adaptive Immunity in Arthritis
by: Stefano Alivernini, et al.
Published: (2018-01-01)